Clinical Trial Update: Clinical Outcomes of Patients Implanted With the RxSight Light Adjustable Lens (LAL)

View source ↗

Summary

Clinical trial update indicates the study evaluating outcomes of patients implanted with the RxSight Light Adjustable Lens has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Pseudophakia

Drugs mentioned

• RxSight Light Adjustable Lens

Snippet

Sponsor: Vance Thompson Vision | Conditions: Cataract, Pseudophakia | Status: WITHDRAWN